- Home
- ACLX vs SAIC Comparison
ACLX vs SAIC Comparison
Compare ACLX & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- SAIC
- Stock Information
- Founded
- ACLX 2015
- SAIC 1969
- Country
- ACLX United States
- SAIC United States
- Employees
- ACLX N/A
- SAIC N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- SAIC EDP Services
- Sector
- ACLX Health Care
- SAIC Technology
- Exchange
- ACLX Nasdaq
- SAIC Nasdaq
- Market Cap
- ACLX 4.1B
- SAIC 4.8B
- IPO Year
- ACLX 2022
- SAIC N/A
- Fundamental
- Price
- ACLX $76.42
- SAIC $102.79
- Analyst Decision
- ACLX Strong Buy
- SAIC Hold
- Analyst Count
- ACLX 13
- SAIC 9
- Target Price
- ACLX $114.75
- SAIC $121.89
- AVG Volume (30 Days)
- ACLX 507.4K
- SAIC 547.5K
- Earning Date
- ACLX 11-06-2025
- SAIC 09-04-2025
- Dividend Yield
- ACLX N/A
- SAIC 1.44%
- EPS Growth
- ACLX N/A
- SAIC 49.05
- EPS
- ACLX N/A
- SAIC 8.26
- Revenue
- ACLX $56,979,000.00
- SAIC $7,460,000,000.00
- Revenue This Year
- ACLX N/A
- SAIC $4.04
- Revenue Next Year
- ACLX $174.18
- SAIC $2.21
- P/E Ratio
- ACLX N/A
- SAIC $12.43
- Revenue Growth
- ACLX N/A
- SAIC 2.23
- 52 Week Low
- ACLX $47.86
- SAIC $94.68
- 52 Week High
- ACLX $107.37
- SAIC $156.34
- Technical
- Relative Strength Index (RSI)
- ACLX 61.10
- SAIC 30.43
- Support Level
- ACLX $73.16
- SAIC $101.96
- Resistance Level
- ACLX $78.61
- SAIC $107.43
- Average True Range (ATR)
- ACLX 2.84
- SAIC 2.93
- MACD
- ACLX 0.55
- SAIC -0.93
- Stochastic Oscillator
- ACLX 75.42
- SAIC 7.68
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.